三氧化二砷可降解NPM-ALK融合蛋白并抑制ALK阳性间变性大细胞淋巴瘤的生长。 - Suppr

Suppr

超能文献

Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma.

作者信息

Piao W, Chau D, Yue L M, Kwong Y-L, Tse E

机构信息

Division of Haematology, Department of Medicine, The University of Hong Kong, Hong Kong, China.

出版信息

Leukemia. 2017 Feb;31(2):522-526. doi: 10.1038/leu.2016.311. Epub 2016 Oct 31.

DOI:10.1038/leu.2016.311

PMID:27795556

Abstract

摘要

相似文献

Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma.

Leukemia. 2017 Feb;31(2):522-526. doi: 10.1038/leu.2016.311. Epub 2016 Oct 31.

ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.

Am J Pathol. 1998 Sep;153(3):875-86. doi: 10.1016/S0002-9440(10)65629-5.

NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair.

Blood Cancer J. 2015 May 15;5(5):e311. doi: 10.1038/bcj.2015.35.

Identification of a novel crosstalk between casein kinase 2α and NPM-ALK in ALK-positive anaplastic large cell lymphoma.

Cell Signal. 2013 Feb;25(2):381-8. doi: 10.1016/j.cellsig.2012.11.005. Epub 2012 Nov 12.

The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation.

Cancer Res. 2008 Nov 1;68(21):8899-907. doi: 10.1158/0008-5472.CAN-08-2568.

The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation.

Phytomedicine. 2015 Aug 15;22(9):862-74. doi: 10.1016/j.phymed.2015.06.003. Epub 2015 Jun 26.

Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas.

Oncogene. 2009 Jul 23;28(29):2690-6. doi: 10.1038/onc.2009.125. Epub 2009 Jun 8.

Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas.

Oncogene. 2008 Apr 24;27(19):2728-36. doi: 10.1038/sj.onc.1210921. Epub 2007 Nov 12.

The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.

Cancer Res. 2006 Sep 15;66(18):9002-8. doi: 10.1158/0008-5472.CAN-05-4101.

Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth.

J Clin Invest. 2015 Sep;125(9):3505-18. doi: 10.1172/JCI78488. Epub 2015 Aug 10.

引用本文的文献

Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy.

Cell Oncol (Dordr). 2024 Feb;47(1):97-112. doi: 10.1007/s13402-023-00853-2. Epub 2023 Aug 24.

Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II.

Front Oncol. 2023 Jun 27;13:1238486. doi: 10.3389/fonc.2023.1238486. eCollection 2023.

Effect of arsenic trioxide plus etoposide, solumedrol, high‑dose cytarabine and cisplatin chemotherapy on the treatment of relapsed or ref7ractory ALK+ anaplastic large cell lymphoma.

Oncol Lett. 2023 May 4;25(6):268. doi: 10.3892/ol.2023.13854. eCollection 2023 Jun.

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond.

Front Oncol. 2022 Nov 18;12:1026478. doi: 10.3389/fonc.2022.1026478. eCollection 2022.

Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin.

Chem Sci. 2021 Jul 17;12(32):10893-10900. doi: 10.1039/d1sc03119h. eCollection 2021 Aug 18.

Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma.

Front Cell Dev Biol. 2020 Jan 15;7:369. doi: 10.3389/fcell.2019.00369. eCollection 2019.

PIN1 in Cell Cycle Control and Cancer.

Front Pharmacol. 2018 Nov 26;9:1367. doi: 10.3389/fphar.2018.01367. eCollection 2018.

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

BMC Cancer. 2018 Oct 1;18(1):940. doi: 10.1186/s12885-018-4840-5.

Mitochondrial toxicity of organic arsenicals: membrane permeability transition pore opening and respiratory dysfunction.

Toxicol Res (Camb). 2017 Dec 19;7(2):191-200. doi: 10.1039/c7tx00234c. eCollection 2018 Mar 1.

Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia.

J Cell Mol Med. 2018 Mar;22(3):1614-1626. doi: 10.1111/jcmm.13436. Epub 2017 Dec 20.

本文引用的文献

Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells.

Blood. 2015 May 28;125(22):3447-54. doi: 10.1182/blood-2014-11-612416. Epub 2015 Mar 23.

Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells.

Blood. 2015 May 28;125(22):3455-65. doi: 10.1182/blood-2014-11-611459. Epub 2015 Mar 20.

Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.

J Clin Oncol. 2013 Jun 1;31(16):1970-6. doi: 10.1200/JCO.2012.44.7524. Epub 2013 Apr 22.

PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.

Cancer Cell. 2010 Jul 13;18(1):88-98. doi: 10.1016/j.ccr.2010.06.003.

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.

Science. 2010 Apr 9;328(5975):240-3. doi: 10.1126/science.1183424.

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

Blood. 2008 Jun 15;111(12):5496-504. doi: 10.1182/blood-2008-01-134270. Epub 2008 Apr 2.

Arsenic trioxide: safety issues and their management.

Acta Pharmacol Sin. 2008 Mar;29(3):296-304. doi: 10.1111/j.1745-7254.2008.00771.x.

Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity.

Leukemia. 2007 Oct;21(10):2117-27. doi: 10.1038/sj.leu.2404891. Epub 2007 Aug 9.

Pathobiology of ALK+ anaplastic large-cell lymphoma.

Blood. 2007 Oct 1;110(7):2259-67. doi: 10.1182/blood-2007-04-060715. Epub 2007 May 22.

What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?

Leukemia. 2005 Jul;19(7):1128-34. doi: 10.1038/sj.leu.2403797.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验